All In Biotech

Drug Trial Radar · NCT00002970

506U78 in Treating Patients With Refractory Hematologic Cancer

A Phase II Study of Compound 506U78 in Patients With Refractory T-Cell Malignancies-POG/CCG Intergroup Study

Last checked: Nov 20, 2026Latest source record: Jul 2, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

148

Actual

Start

Jun 1997

Primary completion

Jan 2005

Sponsor

Sponsor type
NIH
Collaborators
Children's Cancer Group
First posted
Aug 11, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase II trial to study the effectiveness of 506U78 in treating patients with recurrent or refractory hematologic cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Conditions

  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood Lymphoblastic Lymphoma
  • T-cell Childhood Acute Lymphoblastic Leukemia

Interventions

  • nelarabineDrug

    Given IV

  • methotrexateDrug

    Given IT

  • cytarabineDrug

    Given IT

  • therapeutic hydrocortisoneDrug

    Given IT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Early marrow CR plus PR rate at day 21Time frame: Day 21

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Children's Oncology Group

    Arcadia, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.